{"database": "lobbying", "table": "lobbying_activities", "rows": [[2505289, "28c01c46-667d-43fc-bd2f-d4269e42a097", "Q3", "ACG ADVOCACY", 2057, "LYNDRA THERAPEUTICS, INC.", 2020, "third_quarter", "PHA", "Issues related to advanced pharmaceutical and domestic supply chain.", "Health & Human Services, Dept of (HHS),White House Office", 70000, null, 0, 0, "2020-10-08T17:20:31.237000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2505289"], "units": {}, "query_ms": 0.37782895378768444, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}